A carregar...
Development of Natural-Based Bone Cement for a Controlled Doxorubicin-Drug Release
Osteosarcoma (OS) accounts for 60% of all global bone cancer diagnoses. Intravenous administration of Doxorubicin Hydrochloride (DOXO) is the current form of OS treatment, however, systemic delivery has been linked to the onset of DOXO induced cardiomyopathy. Biomaterials including calcium phosphate...
Na minha lista:
| Publicado no: | Front Bioeng Biotechnol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7363953/ https://ncbi.nlm.nih.gov/pubmed/32733869 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00754 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|